12:37 EDT AstraZeneca (AZN) up 1% to $85.55 after MSNBC report on Trump pact
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZN:
- AstraZeneca’s New Trial Targets Sepsis-Related Kidney Injury
- AstraZeneca Launches New Study on NSCLC Treatment Patterns
- AstraZeneca’s New Study Targets Improved Treatment for Elderly LBCL Patients
- AstraZeneca’s OPTIMISE-CKD Study: Insights into Chronic Kidney Disease Management
- AstraZeneca’s Latest Study on AZD5004: Key Insights for Investors